Diligence Reports. Within [***] days after the end of each calendar year until such time as a First Commercial Sale has been achieved in the United States and the objectives set forth in Section 3.1 (b) have been achieved, Company shall report in writing to Hospital on progress made toward such objectives during such preceding 12 month period, including, without limitation, progress on research and development, status of applications for regulatory approvals, manufacturing, sublicensing and the number of sublicenses entered into and marketing.
Appears in 4 contracts
Samples: Exclusive License Agreement, Exclusive License Agreement (OvaScience, Inc.), Exclusive License Agreement (OvaScience, Inc.)
Diligence Reports. Within [***] days after the end of each calendar year until such time as a First Commercial Sale has been achieved in the United States and the objectives set forth in Section 3.1 (b) have been achieved, Company shall report in writing to Hospital on progress made toward such objectives during such preceding 12 month period, including, without limitation, progress on research and development, status of applications for regulatory approvals, manufacturing, sublicensing and the number of sublicenses entered into and marketing.
Appears in 2 contracts
Samples: Exclusive License Agreement (OvaScience, Inc.), Exclusive License Agreement (OvaScience, Inc.)